SCHEMBL31542064

SCHEMBL31542064

O=C(NO)c1ccc(Cc2nc3ccccc3c(=O)n2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
HDAC6 Q9UBN7 5/20 0.57
PDE10A Q9Y233 1/20 0.55
KMT2A Q03164 4/20 0.50
HTR7 P34969 2/20 0.49
HDAC1 Q13547 4/20 0.48
HDAC11 Q96DB2 4/20 0.48
HDAC8 Q9BY41 4/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
TSHR P16473 2/20 0.48
CYP2C19 P33261 2/20 0.48
ADORA3 P0DMS8 1/20 0.48
NPSR1 Q6W5P4 2/20 0.48
HDAC2 Q92769 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HDAC3 O15379 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542055 0.92 NPC1 (0.70) ALDH1A1NPC1RAB9AHDAC6KMT2A
SCHEMBL31542069 0.87 ALDH1A1 (0.75) ALDH1A1NPC1RAB9APDE10AKMT2A
SCHEMBL31542082 0.87 POLB (0.63) ALDH1A1NPC1RAB9APDE10AKMT2A
SCHEMBL31542068 0.85 ALDH1A1 (0.58) ALDH1A1NPC1RAB9AHDAC6KMT2A
SCHEMBL31542049 0.81 NPC1 (0.51) ALDH1A1NPC1RAB9AHDAC6PDE10A
SCHEMBL7018781 0.80 ALDH1A1 (0.60) ALDH1A1NPC1RAB9APDE10AKMT2A
SCHEMBL31542057 0.80 HDAC6 (0.60) ALDH1A1NPC1RAB9AHDAC6KMT2A
SCHEMBL31542070 0.78 HDAC6 (0.62) ALDH1A1NPC1RAB9AHDAC6KMT2A
SCHEMBL31542050 0.78 HDAC6 (0.53) ALDH1A1NPC1RAB9AHDAC6KMT2A
SCHEMBL31542054 0.77 HDAC6 (0.50) ALDH1A1NPC1RAB9AHDAC6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP claimed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO claimed
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP disclosed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO disclosed